These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 30219491)

  • 1. A unique case of buffalo hump after prolonged use of spironolactone.
    Hudd TR; Chugh P; Zaiken K
    J Am Pharm Assoc (2003); 2018; 58(6):679-681. PubMed ID: 30219491
    [No Abstract]   [Full Text] [Related]  

  • 2. [Experience in the therapy of acne with topical administration of spironolactone as an antiandrogen].
    Califano L; Cannavò S; Siragusa M; Girardi R
    Clin Ter; 1990 Nov; 135(3):193-9. PubMed ID: 2150020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spironolactone therapy in hirsutism and acne.
    Callan AW
    Australas J Dermatol; 1988; 29(3):135-9. PubMed ID: 2978784
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of the efficacy of 5% topical spironolactone gel and placebo in the treatment of mild and moderate acne vulgaris: a randomized controlled trial.
    Afzali BM; Yaghoobi E; Yaghoobi R; Bagherani N; Dabbagh MA
    J Dermatolog Treat; 2012 Feb; 23(1):21-5. PubMed ID: 20964565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Spironolactone in dermatological treatment. On and off label indications].
    Salavastru CM; Fritz K; Tiplica GS
    Hautarzt; 2013 Oct; 64(10):762-7. PubMed ID: 24150826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tolerance of spironolactone.
    Hughes BR; Cunliffe WJ
    Br J Dermatol; 1988 May; 118(5):687-91. PubMed ID: 2969259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spironolactone for the Treatment of Acne: A 4-Year Retrospective Study.
    Grandhi R; Alikhan A
    Dermatology; 2017; 233(2-3):141-144. PubMed ID: 28472793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allergic contact dermatitis from spironolactone.
    Corazza M; Strumìa R; Lombardi AR; Virgili A
    Contact Dermatitis; 1996 Dec; 35(6):365-6. PubMed ID: 9118635
    [No Abstract]   [Full Text] [Related]  

  • 9. Spironolactone in dermatologic therapy.
    Shaw JC
    J Am Acad Dermatol; 1991 Feb; 24(2 Pt 1):236-43. PubMed ID: 1826112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse effects of spironolactone therapy in women with acne.
    Lubbos HG; Hasinski S; Rose LI; Pollock J
    Arch Dermatol; 1998 Sep; 134(9):1162-3. PubMed ID: 9762041
    [No Abstract]   [Full Text] [Related]  

  • 11. Tailoring individualized treatment plans for acne.
    Harper JC
    Cutis; 2008 Jan; 81(1 Suppl):23-5. PubMed ID: 18338655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-dose adjunctive spironolactone in the treatment of acne in women: a retrospective analysis of 85 consecutively treated patients.
    Shaw JC
    J Am Acad Dermatol; 2000 Sep; 43(3):498-502. PubMed ID: 10954662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Topical treatment of acne with spironolactone].
    Massone L; Pestarino A; Borghi S
    Clin Ter; 1987 Nov; 123(4):271-3. PubMed ID: 2972488
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects and side-effects of spironolactone therapy in women with acne.
    Yemisci A; Gorgulu A; Piskin S
    J Eur Acad Dermatol Venereol; 2005 Mar; 19(2):163-6. PubMed ID: 15752283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Spironolactone administered topically in the treatment of acne].
    Tomidei M; Strani G
    Clin Ter; 1987 Jul; 122(2):99-105. PubMed ID: 2973907
    [No Abstract]   [Full Text] [Related]  

  • 16. Oral Spironolactone for Acne Vulgaris in Adult Females: An Update of the Literature.
    Barker RA; Wilcox C; Layton AM
    Am J Clin Dermatol; 2020 Apr; 21(2):303-305. PubMed ID: 32166709
    [No Abstract]   [Full Text] [Related]  

  • 17. Spironolactone loaded nanostructured lipid carrier gel for effective treatment of mild and moderate acne vulgaris: A randomized, double-blind, prospective trial.
    Kelidari HR; Saeedi M; Hajheydari Z; Akbari J; Morteza-Semnani K; Akhtari J; Valizadeh H; Asare-Addo K; Nokhodchi A
    Colloids Surf B Biointerfaces; 2016 Oct; 146():47-53. PubMed ID: 27248464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Facial contact dermatitis due to spironolactone in an anti-acne cream.
    Vincenzi C; Trevisi P; Farina P; Stinchi C; Tosti A
    Contact Dermatitis; 1993 Nov; 29(5):277-8. PubMed ID: 8112074
    [No Abstract]   [Full Text] [Related]  

  • 19. Lack of effect of topical spironolactone on sebum excretion.
    Walton S; Cunliffe WJ; Lookingbill P; Keczkes K
    Br J Dermatol; 1986 Feb; 114(2):261-4. PubMed ID: 2936373
    [No Abstract]   [Full Text] [Related]  

  • 20. Spironolactone in dermatology.
    Cunliffe WJ
    J Am Acad Dermatol; 1992 Jan; 26(1):137-8. PubMed ID: 1531055
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.